Checkpoint inhibitors: a new standard of care for advanced Merkel cell carcinoma?

Axel Hauschild¹, Dirk Schadendorf²

Affiliations

¹ Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Kiel, Germany. Electronic address: ahauschild@dermatology.uni-kiel.de.
² Department of Dermatology Comprehensive Cancer Center, University Hospital Essen, Germany; German Cancer Consortium, Heidelberg, Germany (DKTK).

PMID: 27592804
DOI: 10.1016/S1470-2045(16)30441-7

Comment

Checkpoint inhibitors: a new standard of care for advanced Merkel cell carcinoma?

Axel Hauschild et al. Lancet Oncol. 2016 Oct.

. 2016 Oct;17(10):1337-1339.

doi: 10.1016/S1470-2045(16)30441-7. Epub 2016 Sep 1.

Authors

Axel Hauschild¹, Dirk Schadendorf²

Affiliations

¹ Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Kiel, Germany. Electronic address: ahauschild@dermatology.uni-kiel.de.
² Department of Dermatology Comprehensive Cancer Center, University Hospital Essen, Germany; German Cancer Consortium, Heidelberg, Germany (DKTK).

PMID: 27592804
DOI: 10.1016/S1470-2045(16)30441-7

No abstract available

PubMed Disclaimer

Comment on

Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial.
Kaufman HL, Russell J, Hamid O, Bhatia S, Terheyden P, D'Angelo SP, Shih KC, Lebbé C, Linette GP, Milella M, Brownell I, Lewis KD, Lorch JH, Chin K, Mahnke L, von Heydebreck A, Cuillerot JM, Nghiem P. Kaufman HL, et al. Lancet Oncol. 2016 Oct;17(10):1374-1385. doi: 10.1016/S1470-2045(16)30364-3. Epub 2016 Sep 1. Lancet Oncol. 2016. PMID: 27592805 Free PMC article. Clinical Trial.

Cited by

Preclinical evaluation of NF-κB-triggered dendritic cells expressing the viral oncogenic driver of Merkel cell carcinoma for therapeutic vaccination.
Gerer KF, Erdmann M, Hadrup SR, Lyngaa R, Martin LM, Voll RE, Schuler-Thurner B, Schuler G, Schaft N, Hoyer S, Dörrie J. Gerer KF, et al. Ther Adv Med Oncol. 2017 Jul;9(7):451-464. doi: 10.1177/1758834017712630. Epub 2017 Jun 13. Ther Adv Med Oncol. 2017. PMID: 28717398 Free PMC article.
Immune Checkpoint Inhibitor Nephrotoxicity: Update 2020.
Gupta S, Cortazar FB, Riella LV, Leaf DE. Gupta S, et al. Kidney360. 2020 Jan 14;1(2):130-140. doi: 10.34067/KID.0000852019. eCollection 2020 Feb 27. Kidney360. 2020. PMID: 35372904 Free PMC article. Review.
Neoadjuvant Nivolumab for Patients With Resectable Merkel Cell Carcinoma in the CheckMate 358 Trial.
Topalian SL, Bhatia S, Amin A, Kudchadkar RR, Sharfman WH, Lebbé C, Delord JP, Dunn LA, Shinohara MM, Kulikauskas R, Chung CH, Martens UM, Ferris RL, Stein JE, Engle EL, Devriese LA, Lao CD, Gu J, Li B, Chen T, Barrows A, Horvath A, Taube JM, Nghiem P. Topalian SL, et al. J Clin Oncol. 2020 Aug 1;38(22):2476-2487. doi: 10.1200/JCO.20.00201. Epub 2020 Apr 23. J Clin Oncol. 2020. PMID: 32324435 Free PMC article. Clinical Trial.
Targeting Merkel Cell Carcinoma by Engineered T Cells Specific to T-Antigens of Merkel Cell Polyomavirus.
Gavvovidis I, Leisegang M, Willimsky G, Miller N, Nghiem P, Blankenstein T. Gavvovidis I, et al. Clin Cancer Res. 2018 Aug 1;24(15):3644-3655. doi: 10.1158/1078-0432.CCR-17-2661. Epub 2018 Apr 18. Clin Cancer Res. 2018. PMID: 29669806 Free PMC article.
A rare case of Merkel cell carcinoma presenting as a giant intra-thoracic mass: A case report and review of the literature.
Kong FW, Zhang M, Wang H, Lu CT, Wu WB, Liu YY. Kong FW, et al. Medicine (Baltimore). 2017 Nov;96(46):e8743. doi: 10.1097/MD.0000000000008743. Medicine (Baltimore). 2017. PMID: 29145324 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Checkpoint inhibitors: a new standard of care for advanced Merkel cell carcinoma?

Affiliations

Checkpoint inhibitors: a new standard of care for advanced Merkel cell carcinoma?

Authors

Affiliations

Comment on

Similar articles

Cited by

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources